Milestone Scientific

Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs. Its solutions include CompuFlo Epidural, CathCheck Verification System, and Single Tooth Anesthesia System. The company was founded on August 17, 1989 and is headquartered in Roseland, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Milestone Scientific reports Q1 revenue, eyes international expansion opportunities

Milestone Scientific's Q1 2024 performance showed revenue over $2.2 million with improved gross margins.
The company's focus on customer relationships and reimbursement strategies is a key strength.
Challenges include revenue decrease and the need for endorsements in the medical space.
Opportunities lie in international expansion, market penetration goals, and increased marketing efforts.

Milestone Scientific reports improved Q2 performance amidst revenue challenges

Milestone Scientific showcased financial improvements in Q2 2024 despite a revenue decrease, with a focus on enhancing operational efficiency and achieving positive cash flow.
The company's strategic partnerships, international expansion plans, and commitment to innovation through intellectual property enhancements signal a path for future growth and market competitiveness.
While facing challenges in revenue generation and operational clarity, Milestone Scientific's strong balance sheet and market positioning offer opportunities for sustained growth and profitability.

Milestone Scientific reports revenue growth and strategic partnerships in Q3

Milestone Scientific shows promising revenue growth and operational improvements in Q3 2024, driven by strong Dental division performance and international sales.
Strategic partnerships and a solid financial position enhance market reach and provide a foundation for future growth.
Challenges include reducing net losses, driving market adoption of CompuFlo, and navigating Medicare coverage expansion, while opportunities exist in reimbursement initiatives and market expansion post-approvals.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ROSELAND, N.J., March 31, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ending December 31, 2022.

Milestone Scientific Provides 2022 Year-End Business Update

ROSELAND, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, March 31, 2023, to discuss the company's financial results for 2022, as well as the company's corporate progress and other developments.

Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call

Follows successful evaluation by its Medical Director and Founder, Dr. Didier Demesmin, MD, MBA Follows successful evaluation by its Medical Director and Founder, Dr. Didier Demesmin, MD, MBA

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the University Pain and Spine Center which Operates 7 Locations Across New Jersey and New York

Follows successful evaluation by Dr. Brad Sisson, MD, including complex thoracic procedures Follows successful evaluation by Dr. Brad Sisson, MD, including complex thoracic procedures

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Three Prominent Colorado Pain Management Clinics

SAM approval marks an important step in gaining entrée to the Department of Defense, Veterans Affairs and other government agencies SAM approval marks an important step in gaining entrée to the Department of Defense, Veterans Affairs and other government agencies

Milestone Scientific Granted U.S. Government's System for Award Management (SAM) Registration of its CompuFlo® Epidural System

ROSELAND, NJ., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced that its CompuFlo® Epidural System has received 510(k) FDA clearance for use in the thoracic region of the spine, including the cervical thoracic junction. This approval expands upon the Company's prior approval of CompuFlo for use within the lumbar region of the spine, where the focus has been on labor and delivery.

Milestone Scientific Announces 510(k) FDA Clearance for the Use of CompuFlo Epidural System in Thoracic Indications

Sweden & Martina has been Awarded Exclusive Distribution Rights to Milestone's STA Single Tooth Anesthesia System® in Italy, Spain, Portugal and France Sweden & Martina has been Awarded Exclusive Distribution Rights to Milestone's STA Single Tooth Anesthesia System® in Italy, Spain, Portugal and France

Milestone Scientific Announces Distribution Agreement with Leading European Dental Distributor & Manufacturer Sweden & Martina

ROSELAND, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced it has entered into a distribution agreement granting TEKMIKA Health Technologies exclusive distribution rights to market Milestone's STA Single Tooth Anesthesia System® (STA) in Brazil. TEKMIKA Health Technologies is a leading distributor in Brazil, focused on importing, promotion, marketing and distribution of high-tech medical equipment and devices.

Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil

ROSELAND, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Neal Goldman as Chairman of the Board of Directors. Mr. Goldman has served on the Company's board since 2019 and succeeds Leslie Bernhard, who has resigned following years of dedicated service.

Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman as Chairman of the Board of Directors

Milestone Scientific Inc. (NYSE:MLSS ) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Conference Call Participants Anthony Vendetti - Maxim Group Operator Good day ladies and gentlemen and welcome to the Milestone Scientific's Third Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation.

Milestone Scientific Inc. (MLSS) Q3 2022 Earnings Call Transcript

Reports 34.4% sequential increase in sales over the second quarter of 2022 Reports 34.4% sequential increase in sales over the second quarter of 2022

Milestone Scientific Achieves Revenue of $2.2 Million for the Third Quarter of 2022

ROSELAND, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 15, 2022, to discuss the company's financial results for the third quarter ended September 30, 2022, as well as the company's corporate progress and other developments.

Milestone Scientific Schedules Third Quarter 2022 Financial Results and Business Update Conference Call

ROSELAND, NJ / ACCESSWIRE / October 6, 2022 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, has been invited to present at the 2022 MicroCap Rodeo Windy City Roundup Conference, which is being held on October 12 - 13, 2022 in Chicago, Illinois. Mr. Haverhals is scheduled to present on Wednesday, October 12th at 2:30 p.m.

Milestone Scientific to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th

ROSELAND, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful evaluation, it has commenced sales of its CompuFlo® Epidural disposables to UofL Health (University of Louisville), a leading academic health system based in Louisville, Kentucky. UofL Health owns and operates six hospitals and four medical centers, providing patient care to more than 1.5 million patients each year in the state of Kentucky. UofL Health has begun implementing the CompuFlo Epidural System for obstetric anesthesia, acute pain, and chronic pain within its labor and delivery (L&D), operating room (OR) and pain clinic teams.

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables Across Three Departments within UofL Health

Milestone Scientific Inc. (NYSE:MLSS ) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communications, IR Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen. Thank you for standing by.

Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q2 2022 Results - Earnings Call Transcript

ROSELAND, N.J., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June 30, 2022.

Milestone Scientific Provides Business Update for the Second Quarter of 2022

ROSELAND, N.J., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, August 16, 2022, to discuss the company's financial results for the second quarter ended June 30, 2022, as well as the company's corporate progress and other developments.

Milestone Scientific Schedules Second Quarter 2022 Financial Results and Business Update Conference Call

New distribution agreement follows adoption of CompuFlo® Epidural System at key hospitals, healthcare systems and pain management clinics New distribution agreement follows adoption of CompuFlo® Epidural System at key hospitals, healthcare systems and pain management clinics

Milestone Scientific Announces Distribution Agreement with Clinical Technology, Inc. for the CompuFlo® Epidural System

ROSELAND, N.J., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it has commenced sales of the CompuFlo® Epidural system to the University of Scranton for incorporation into the student registered nurse anesthesia (SRNA) program.

Milestone Scientific Commences Sales of its CompuFlo® Epidural System to the University of Scranton for Incorporation in their Student Registered Nurse Anesthesia Curriculum

The company has a very attractive razor and blade business model. Device sales produce a large and long tail of demand for high-margin consumables. So it doesn't take much in terms of an increase of the installed base to deliver a long-lasting improvement in financials.

Milestone Scientific Is Close To A Sustainable Financial Path

ROSELAND, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it has entered into a distribution agreement granting Hager & Werken exclusive distribution rights to market Milestone's STA Single Tooth Anesthesia System® (STA) in Germany and Austria.

Milestone Scientific Names Hager & Werken as Exclusive STA Single Tooth Anesthesia System® Distributor in Germany and Austria

ROSELAND, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today signed an exclusive distribution agreement in Greece for the CompuFlo ® Epidural System with F&M Feed, a leading provider of medical equipment, devices and consumables. In connection with the agreement, Milestone Scientific has commenced sales and shipments of its CompuFlo Epidural Instrument and consumables to Greece.

Milestone Scientific Inc. Announces F&M Feed as an Exclusive Distributor in Greece and Commences Sales of CompuFlo® Epidural Instrument

ROSELAND, N.J., July 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful trial and evaluation, it has commenced sales of its CompuFlo® Epidural disposables to a leading medical center in Southern California, which has been designated as one of the Best Maternity Care Hospitals by Newsweek. This medical center also belongs to one of the nation's largest not-for-profit healthcare systems serving over 10 million members, with more than 100,000 babies delivered each year across multiple states.

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables to a Leading Medical Center in Southern California

Expands potential for reimbursement of epidural procedures in pain management utilizing the CompuFlo Epidural System Expands potential for reimbursement of epidural procedures in pain management utilizing the CompuFlo Epidural System

American Medical Association Issues Technology-Specific CPT® Code for Milestone Scientific's CompuFlo Epidural System

ROSELAND, N.J., May 27, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that it has commenced sales of its CompuFlo ® Epidural instrument disposables at a leading veterinary and academic institution following a successful research study and evaluation. The veterinary institution has initially begun using the CompuFlo Epidural instrument for maxillary nerve block procedures in horses with plans to expand into epidural procedures.

Milestone Scientific Expands Medical Indications for the CompuFlo® Epidural Instrument and Commences Disposable Sales to a Leading Veterinary and Academic Institution

News for Milestone Scientific Stock (MLSS)